At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
An Open-Label, 2-Part Study to Investigate the Effect of Lasmiditan on the Pharmacokinetics of Dabigatran and Rosuvastatin in Healthy Volunteers
In Brief
A Phase 1 clinical trial evaluating Lasmiditan, Dabigatran Etexilate, and 1 other intervention for Healthy. Completed, enrolled 97 participants across 1 site.
Detailed Summary
The main purpose of the study is to investigate the blood concentrations of dabigatran etexilate and rosuvastatin when taken alone compared to when taken together with lasmiditan in healthy participants. The safety and tolerability of dabigatran etexilate or rosuvastatin in combination with lasmiditan will also be evaluated in healthy participants. The study has two parts. Each part will last up to 17 days, not including screening.
Study Details
Timeline
Interventions
Administered orally.
Administered orally.
Administered orally.